Literature DB >> 9533262

Statistical methods for population pharmacokinetic modelling.

A Racine-Poon1, J Wakefield.   

Abstract

A principal aim of population pharmacokinetic studies is to estimate the variance components associated with intra- and inter-individual variability in observed drug concentrations. The explanation of the inter-individual variability in terms of subject-specific covariates is also of great importance. Pharmacokinetic models are nonlinear in the parameters and estimation is not straightforward. Within this paper we review a number of estimation approaches which have been suggested for population pharmacokinetic analyses. We distinguish between Bayesian and non-Bayesian and fully-parametric, semi-parametric and nonparametric methods.

Mesh:

Substances:

Year:  1998        PMID: 9533262     DOI: 10.1177/096228029800700106

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  18 in total

1.  Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans.

Authors:  Paolo Boffetta; Deborah M Winn; John P Ioannidis; Duncan C Thomas; Julian Little; George Davey Smith; Vincent J Cogliano; Stephen S Hecht; Daniela Seminara; Paolo Vineis; Muin J Khoury
Journal:  Int J Epidemiol       Date:  2012-05-16       Impact factor: 7.196

2.  Fuzzy simulation of pharmacokinetic models: case study of whole body physiologically based model of diazepam.

Authors:  Ivelina I Gueorguieva; Ivan A Nestorov; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-06       Impact factor: 2.745

3.  Non-linear mixed-effects models with stochastic differential equations: implementation of an estimation algorithm.

Authors:  Rune V Overgaard; Niclas Jonsson; Christoffer W Tornøe; Henrik Madsen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

4.  How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approach.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  Eur J Clin Pharmacol       Date:  2008-05-16       Impact factor: 2.953

5.  A novel global search algorithm for nonlinear mixed-effects models using particle swarm optimization.

Authors:  Seongho Kim; Lang Li
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-06-30       Impact factor: 2.745

Review 6.  Gene--environment-wide association studies: emerging approaches.

Authors:  Duncan Thomas
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

Review 7.  Use of pathway information in molecular epidemiology.

Authors:  Duncan C Thomas; David V Conti; James Baurley; Frederik Nijhout; Michael Reed; Cornelia M Ulrich
Journal:  Hum Genomics       Date:  2009-10       Impact factor: 4.639

8.  Population pharmacokinetic modeling of a subcutaneous depot for GnRH antagonist degarelix.

Authors:  Christoffer W Tornøe; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

9.  Bayesian immunological model development from the literature: example investigation of recent thymic emigrants.

Authors:  Tyson H Holmes; David B Lewis
Journal:  J Immunol Methods       Date:  2014-08-29       Impact factor: 2.303

10.  Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects.

Authors:  Navindra P Seeram; Yanjun Zhang; Rodney McKeever; Susanne M Henning; Ru-po Lee; Marc A Suchard; Zhaoping Li; Steve Chen; Gail Thames; Alona Zerlin; Martha Nguyen; David Wang; Mark Dreher; David Heber
Journal:  J Med Food       Date:  2008-06       Impact factor: 2.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.